300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Luxembourg
Marshall Islands
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
South Africa
Botswana
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Indonesia
United States
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Scottish Investment Bank, VC Fund

Scottish Investment Bank

VC Fund

Glasgow, United Kingdom

Scottish Investment Bank is a VC fund in Glasgow focused on Software and Biotechnology. They help companies to identify appropriate sources of finance, engage with funders and secure the investment they need to grow their business.They work closely with their portfolio companies to strengthen their management teams, make connections and accelerate growth.Their work also involves aiming to increase the supply of finance forbusinesses in Scotland. they want to help Scottish SMEs with growth and export potential to get this finance.Apart from supporting Scottish businesses, they also work with UK and international investors. This includes working with business angels, angel syndicates, venture capital groups and corporate investors.They operate across Scotland in partnership with Highlands and Islands Enterprise. Because their work supports and stimulates the SME funding market in Scotland, what they do supports the delivery of the Scottish Enterprise business plan.

Total investments:
276
Last investment:
Lead investor:
13%
Last fund:

Last updated:

Industries Scottish Investment Bank invests in

SoftwareBiotechnologyHealth CareInformation TechnologyMedical

Stages Scottish Investment Bank invests in

Venture - Series UnknownSeedSeries AFunding RoundSeries B

Countries Scottish Investment Bank invests in

United KingdomUnited StatesFrance

Round sizes

Seed $331k–$3.1MSeries A $1.7M–$7.5MVenture - Series Unknown $244k–$4.1M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$331k–$3.1M
Series A
$1.7M–$7.5M
Venture - Series Unknown
$244k–$4.1M

Investment Focus

Industry

  • Software 35 (13%)
  • Biotechnology 30 (11%)
  • Health Care 27 (10%)
  • Information Technology 27 (10%)
  • Medical 13 (5%)
See all 179 industries →

Stage

  • Venture - Series Unknown 51 (18%)
  • Seed 44 (16%)
  • Series A 37 (13%)
  • Funding Round 29 (11%)
  • Series B 11 (4%)
See all 13 stages →

Country

  • United Kingdom 130 (47%)
  • United States 8 (3%)
  • France 2 (1%)

Team

NameTitleInvestmentsLinksEmail
Crawford Gillies
Crawford Gillies Chairman
Chairman Total investments: 0
Find email
Jeremy Peat
Jeremy Peat Enterprise Board
Enterprise Board Total investments: 0
Find email
Susan Armes
Susan Armes Head of the Scottish Investment Bank
Head of the Scottish Investment Bank Total investments: 61
Find email

Investments

CompanyDescriptionRoundLinks
The growth in IoT is explosive, impressive and unsustainable under current architectural approaches. Many IoT deployments face challenges related to latency, network bandwidth, reliability and security, which cannot be addressed in cloud-only models. Venture - Series Unknown / Aug 29, 2023
BDD is a specialist drug formulation company providing expertise across all areas of drug delivery. We offer a full service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing.Our patented time release technology OralogiK provides unrivaled control of drug release at the right place andtime. OralogiK has been validated in numerous clinical studies, enables the oral delivery of single, multi-dose or combination drugs at pre-determined times between one and 12 hours after being swallowed by the patient. This facilitates such benefits as: night time dosing of a drug to be delivered pre-wakeup multi-phased delivery of one or more drugs (immediate and delayed) to allow once-a-day dosing or for pre-treatment by one drug before the delivery of a second delivery of drugs to a specific regions of the digestive system (e.g. the colon) BDD also specialize in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report. $2.5M / Venture - Series Unknown / Aug 16, 2023
Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program. $6.5M / Jul 11, 2023
A bio pharmaceutical spin out emerging from the University of Glasgow, working in the orthobiologic therapeutic space. Intellectual property has been generated via academic research demonstrating a proven mechanistic reasoning for the use of a microRNA therapy in the treatment of tendinopathies. $10.5M / Venture - Series Unknown / Feb 22, 2023
Shot Scope's statistic collecting technology is currently in development, led by a team of engineers and golfers based in Edinburgh, United Kingdom. Trials are planned on UK golf courses throughout 2015 with general release scheduled for 2016. $3.3M / Series A / Dec 13, 2022
Speech Graphics delivers pioneering facial animation technology to the entertainment industry, working with clients such as Warner Brothers and Def Jam Recordings. Based on over 20 years of R&D in speech technology and procedural facial dynamics, our software produces high-quality facial animation from audio alone, with no need for motioncapture. Speech Graphics spun out of the University of Edinburgh’s world-renowned School of Informatics in 2010 under the leadership of founders Michael Berger and Gregor Hofer, and game industry veteran Colin Macdonald.Speech Graphics has won several awards for its speech-driven animation technology, including the prestigious John Logie Baird Award for innovation, an LT-Innovate Award, a Santander Entrepreneurial Award, and game industry awards including a 2015 Develop Award for Best Creative Outsourcer and 2015 TIGA Award for Best Animation Supplier. The company has also received several development grants, including grants from Scottish Enterprise and the University of Abertay. $7M / Series A / Feb 23, 2022
ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and commercialise novel patented technology which transforms the production economics for the meat-free food product mycoprotein by integrating the production within existing bio-refinery operations producing bio-ethanol and animal feed (DDGS). Thisgives integrated fermentation production of Food, Fuel and Feed. ​ $49.9M / Series B / Jun 20, 2021
Boundary Technologies Ltd is a revolutionary new way to protect your home and family. Offering 'security as a service', the Boundary home security system will be accurate enough to provide an automatic police response and will also be the only truly smart alarm system to meet UK and European alarm standards. $5.2M / Seed / May 26, 2021
Red61 has grown out of a desire to build a different kind of ticketing solution supplier. Frustrated with the state of the ticketing market and the seemingly endless cycle of dissatisfied ticketing organisations moving to new suppliers, Red61 founders, Box Office Manager Tony Davey and software designer Peter McNaught got together to create acompany whose guiding principle is to create long term collaborative relationships with its clients. $1.8M / May 18, 2021
Red61 has grown out of a desire to build a different kind of ticketing solution supplier. Frustrated with the state of the ticketing market and the seemingly endless cycle of dissatisfied ticketing organisations moving to new suppliers, Red61 founders, Box Office Manager Tony Davey and software designer Peter McNaught got together to create acompany whose guiding principle is to create long term collaborative relationships with its clients. $2M / Seed / May 18, 2021
See all 276 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Luxembourg
Marshall Islands
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
South Africa
Botswana
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Indonesia
United States
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Scottish Investment Bank invest in?

Scottish Investment Bank invests primarily in Software, Biotechnology and Health Care startups, most often at Venture - Series Unknown and Seed stage. Most of the 276 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Scottish Investment Bank's check size?

Scottish Investment Bank typically joins rounds of $331k–$3.1M at Seed, $1.7M–$7.5M at Series A and $244k–$4.1M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Scottish Investment Bank participates in.

How do I contact Scottish Investment Bank?

Public channels for Scottish Investment Bank include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Scottish Investment Bank?

The team at Scottish Investment Bank includes Crawford Gillies (Chairman), Jeremy Peat (Enterprise Board) and Susan Armes (Head of the Scottish Investment Bank). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Scottish Investment Bank Scottish Investment Bank Find emails